No Data
No Data
Nautilus Biotechnology Inc.: Jefferies assumes the insured amount is a position and buy rating; target share price is $3 to $5
Nautilus Biotechnology Inc.: Jefferies assumes the insured amount is a position and buy rating; target share price is $3 to $5
Express News | Nautilus Biotechnology Inc : Jefferies Assumes Coverage With Hold Vs Buy Rating; Price Target $3 Vs $5
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform, today announced the company wi
Nautilus Biotechnology's ESG Challenge: Navigating the Rising Tide of Corporate Responsibility Standards
Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...
Earnings Call Summary | Nautilus Biotechnology(NAUT.US) Q1 2024 Earnings Conference
The following is a summary of the Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript:Financial Performance:Nautilus Biotechnology reported Q1 2024 total operating expenses of $21.6 m